Altria to Acquire NJOY for $2.75 Billion

MarketNews by 2FIRSTS.ai
May.29.2023
Altria to Acquire NJOY for $2.75 Billion
Altria is set to acquire NJOY for $2.75 billion, gaining control of the largest e-cigarette category in the US.

Recently, according to reports from ConvenienceStore, Altria is actively pursuing a deal to acquire NJOY Holdings for $2.75 billion. The company announced that the waiting period, as stipulated by the 1976 Hart-Scott-Rodino Antitrust Improvements Act, has ended and there is no further need for regulatory scrutiny by the Federal Trade Commission.

 

It is expected that this transaction will be completed in the second quarter of 2023, subject to meeting standard transaction conditions. The terms of the deal also include an additional $500 million cash payment, contingent upon the regulatory outcome of NJOY products.

 

Altria CEO Billy Gifford stated during the announcement of the acquisition:

 

We believe that we can responsibly accelerate the use of NJOY ACE products among adult smokers and adult e-cigarette users in the United States, which is something that NJOY, as an independent company, cannot achieve.

 

He also stated:

 

We believe that our business resources can benefit tobacco consumers and expand competition. We are also pleased to welcome NJOY's excellent employees to Altria after the transaction is completed.

 

According to reports from Gifford, Altria will have global ownership over the three largest categories of smokeless products and technologies, as well as a joint venture with JT Group, after completing the acquisition. This move is expected to aid in the promotion of heated tobacco products in the United States.

 

According to reports, the electronic cigarette category is the largest smokeless category in the United States, attracting nearly 14 million American adult tobacco consumers in 2022, including 9.5 million adult electronic cigarette users.

 

During Altria's Investor Day conference on March 23rd, the company announced that its sales of smokeless products would increase by at least 35% from their 800 million unit base in 2022, reaching a revenue of $5 billion by 2028. $2 billion of this revenue is expected to come from the company's innovative smokeless products.

 

Reference(s):

 

The Altria and NJOY agreement is nearing completion.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.
PMI
Mar.23
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13